A
Price
$121.38
Change
+$0.72 (+0.60%)
Updated
Jul 3 closing price
Capitalization
42.66B
46 days until earnings call
ILMN
Price
$100.34
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
21.09B
34 days until earnings call
Interact to see
Advertisement

A vs ILMN

Header iconA vs ILMN Comparison
Open Charts A vs ILMNBanner chart's image
Agilent Technologies
Price$121.38
Change+$0.72 (+0.60%)
Volume$944.96K
Capitalization42.66B
Illumina
Price$100.34
Change-$0.00 (-0.00%)
Volume$2.28K
Capitalization21.09B
A vs ILMN Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ILMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. ILMN commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Buy and ILMN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (A: $121.38 vs. ILMN: $100.80)
Brand notoriety: A: Not notable vs. ILMN: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 47% vs. ILMN: 64%
Market capitalization -- A: $42.66B vs. ILMN: $21.09B
A [@Medical Specialties] is valued at $42.66B. ILMN’s [@Medical Specialties] market capitalization is $21.09B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileILMN’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • ILMN’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than ILMN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while ILMN’s TA Score has 3 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 4 bearish.
  • ILMN’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, A is a better buy in the short-term than ILMN.

Price Growth

A (@Medical Specialties) experienced а +1.86% price change this week, while ILMN (@Medical Specialties) price change was +7.05% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

A is expected to report earnings on Aug 19, 2025.

ILMN is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than ILMN($21.1B). ILMN has higher P/E ratio than A: ILMN (49.50) vs A (34.82). A YTD gains are higher at: -9.264 vs. ILMN (-24.568). A has higher annual earnings (EBITDA): 1.69B vs. ILMN (-608M). ILMN has less debt than A: ILMN (2.26B) vs A (2.56B). A has higher revenues than ILMN: A (6.74B) vs ILMN (4.5B).
AILMNA / ILMN
Capitalization42.7B21.1B202%
EBITDA1.69B-608M-278%
Gain YTD-9.264-24.56838%
P/E Ratio34.8249.5070%
Revenue6.74B4.5B150%
Total CashN/A1.05B-
Total Debt2.56B2.26B113%
FUNDAMENTALS RATINGS
A vs ILMN: Fundamental Ratings
A
ILMN
OUTLOOK RATING
1..100
2030
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
64100
SMR RATING
1..100
4795
PRICE GROWTH RATING
1..100
5345
P/E GROWTH RATING
1..100
5795
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for ILMN (77). This means that A’s stock grew somewhat faster than ILMN’s over the last 12 months.

A's Profit vs Risk Rating (64) in the Biotechnology industry is somewhat better than the same rating for ILMN (100). This means that A’s stock grew somewhat faster than ILMN’s over the last 12 months.

A's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for ILMN (95). This means that A’s stock grew somewhat faster than ILMN’s over the last 12 months.

ILMN's Price Growth Rating (45) in the Biotechnology industry is in the same range as A (53). This means that ILMN’s stock grew similarly to A’s over the last 12 months.

A's P/E Growth Rating (57) in the Biotechnology industry is somewhat better than the same rating for ILMN (95). This means that A’s stock grew somewhat faster than ILMN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AILMN
RSI
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
71%
Declines
ODDS (%)
Bearish Trend 5 days ago
60%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ILMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ETV13.940.08
+0.58%
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
MIY11.070.03
+0.27%
Blackrock Muniyield Michigan Quality Fund
NUHY21.650.03
+0.13%
Nuveen ESG High Yield Corporate Bd ETF
XAPR35.08N/A
N/A
FT Vest US Eq Enh & Mod Buf ETF-Apr
EEMO16.93-0.03
-0.21%
Invesco S&P Emerging Markets Mom ETF

ILMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ILMN has been loosely correlated with A. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if ILMN jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ILMN
1D Price
Change %
ILMN100%
+0.46%
A - ILMN
66%
Loosely correlated
+0.60%
RVTY - ILMN
66%
Loosely correlated
+0.41%
BRKR - ILMN
64%
Loosely correlated
-0.02%
BIO - ILMN
61%
Loosely correlated
+0.36%
MTD - ILMN
60%
Loosely correlated
+0.28%
More